Sign inGet started

Moran Susan

Insider CIK 1835225 · CBIO Director · RYZB Chief Medical Officer · BCAB Director · TYRA Director

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
CBIO CRESCENT BIOPHARMA, INC. A Award deriv2026-06-022026-06-0311,050— $011,050SEC↗
TYRA Tyra Biosciences, Inc. A Award deriv2026-05-282026-06-0113,160— $013,160SEC↗
CBIO GLYCOMIMETICS INC A Award deriv2025-06-232025-06-239,023— $09,023SEC↗
BCAB BioAtla, Inc. A Award2025-06-182025-06-1823,500— $052,307SEC↗
TYRA Tyra Biosciences, Inc. A Award deriv2025-05-292025-06-0222,200— $022,200SEC↗
BCAB BioAtla, Inc. A Award2024-06-132024-06-1416,500— $028,807SEC↗
TYRA Tyra Biosciences, Inc. A Award deriv2024-05-072024-05-0937,200— $037,200SEC↗
RYZB RayzeBio, Inc. D To issuer deriv2024-02-262024-02-27194,514— $00SEC↗
RYZB RayzeBio, Inc. D To issuer deriv2024-02-262024-02-2760,757— $00SEC↗
RYZB RayzeBio, Inc. D To issuer deriv2024-02-262024-02-2777,805— $00SEC↗
RYZB RayzeBio, Inc. D To issuer deriv2024-02-262024-02-27164,000— $00SEC↗
RYZB RayzeBio, Inc. D To issuer2024-02-262024-02-27323,455$62.50 $20.22M0SEC↗
RYZB RayzeBio, Inc. M Exercise deriv2024-01-222024-02-0630,875— $060,757SEC↗
RYZB RayzeBio, Inc. M Exercise2024-01-222024-02-0630,875$3.24 $100.0K322,647SEC↗
RYZB RayzeBio, Inc. A Award deriv2023-11-172023-11-17164,000— $0164,000SEC↗
BCAB BioAtla, Inc. A Award deriv2023-06-142023-06-1550,000— $050,000SEC↗
BCAB BioAtla, Inc. A Award deriv2022-06-162022-06-1720,000— $020,000SEC↗
BCAB BioAtla, Inc. A Award deriv2021-06-152021-06-1612,307— $012,307SEC↗